Women for Science Luncheon 2024

It was an honor to gather at the Women’s Athletic Club in Chicago, bringing together remarkable leaders, scientists, and philanthropists to celebrate cutting-edge research at the Weizmann Institute of Science.

Dr. Sharon Fireman, head of the innovation and translational research at Bina, shared insights into Bina's critical role in turning groundbreaking discoveries into real-world applications.

Dr. Ulyana Shimanovich, principal investigator in Weizmann’s Department of Molecular Chemistry and Materials Science, highlighted her incredible work on protein nanofibrils and their applicative potential, such as in to revolutionize treatments for neurodegenerative diseases and their potential is several biomed applications.

The discussions highlighted the importance of promoting science and innovation. We are grateful for the dedication and passion of everyone involved in making this event possible, including our esteemed co-chairs and generous supporters.

Thank you to the ACWIS team, David Doneson, Rebecca Serber, Helen Riew Miller, and everyone involved in organizing this wonderful event.

Thank you to all who joined us.

More News

Collaboration in Action: WIS & Institut Pasteur advancing Malaria Research

At Bina - Bridge Innovate Nurture Advance, we facilitate meaningful collaborations that bridge exceptional research teams across the globe.
Recently, Daniel Ben- Hur and Edo Kiper from Neta Regev-Rudzky lab at the Weizmann Institute of Science visited the Institut Pasteur in France as part of a joint initiative led by Bina to advance malaria research.

Bina’s drug discovery program - Deadline for pre-proposal submission 12/12/24

Bina is launching a new program for drug discovery that aims to identify scientific breakthroughs in biological processes, disease mechanisms and potential drug targets that can serve as the basis for the development of new drugs and therapies. All projects will be mentored and supervised by Bina’s teams and professional advisors.

Funding amount: up to $500,000
Funding period: 24-36 months

ABC CHATS- Michal Tsur from Remepy

Inspiring Talk with Dr. Michal Tsur: "From startup to a public company – an open conversation".

We were honored to host Dr. Michal Tsur, co-founder and co-CEO of Remepy, at our ABC chat meetup! As a serial entrepreneur and leader in biotech and tech, Michal shared her inspiring journey from co-founding Cyota and Kaltura to leading Remepy, the pioneer of hybrid drugs company.

Key Takeaways:
Build the Right Team: Success starts with passionate, capable individuals who share your vision.